v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Costs and expenses:        
Research and development $ 893 $ 1,368 $ 2,128 $ 2,898
Selling, general and administrative 730 683 1,761 1,879
Total costs and expenses 1,623 2,051 3,889 4,777
Operating loss (1,623) (2,051) (3,889) (4,777)
Other income (expense):        
Total other income, net 10 2 17 16
Net loss $ (1,613) $ (2,049) $ (3,872) $ (4,761)
Net loss per share, basic (in dollars per share) $ (0.13)   $ (0.34)  
Net loss per share, diluted (in dollars per share)   $ (0.4)   $ (0.98)
Weighted-average shares used in computing net loss per share, basic (in shares) 12,093,268   11,456,382  
Weighted-average shares used in computing net loss per share, diluted (in shares)   5,059,736   4,848,922